Načítá se...
Progression to colectomy in the era of biologics: A single center experience with pediatric ulcerative colitis
BACKGROUND/PURPOSE: Clinical outcomes in pediatric ulcerative colitis (UC) in the era of biologic agents are poorly defined. We aimed to describe risk factors for colectomy in pediatric UC in the era of infliximab therapy. METHODS: We reviewed 217 pediatric patients at Texas Children’s Hospital with...
Uloženo v:
| Vydáno v: | J Pediatr Surg |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7396289/ https://ncbi.nlm.nih.gov/pubmed/32087936 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpedsurg.2020.01.054 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|